top of page

Regenerating Health, Restoring Hope

JY BioMed harnesses the power of engineered immune cells and biologics to treat cancer, chronic inflammation, and degenerative diseases.
From bench to bedside, our integrated R&D pipeline accelerates the journey of discovery — driven by purpose, powered by technology.

Image by Fusion Medical Animation

Advance Cell Therapies

Pioneering the next generation of regenerative and immunotherapies.

實驗工作

Translate Science into Impact

From lab bench to bedside, innovation drives every step.

Image by Benjamin Davies

Build a Healthier Future

We don’t just treat disease — we redefine what’s possible.

Our Services

Our Technology Platforms

We develop next-generation cell and exosome therapies that redefine how cancer, aging, and immune diseases are treated — with science, precision, and hope.

DC-based Cancer Vaccine

Our dendritic cell vaccines present tumor antigens to T cells, guiding the immune system to precisely identify and attack cancer cells.

Gamma Delta T 

Our gamma delta T cells rapidly detect and kill cancer cells without MHC restriction, offering a fast, versatile, and potent immunotherapy solution.

Anti-CEACAM6 ADC

Our anti-CEACAM6 ADC delivers potent chemotherapy directly to tumors, combining precision targeting with powerful anti-cancer activity.

MSC

Our MSCs promote tissue repair, reduce inflammation, and neural regeneration across a wide range of conditions.

Exosome

Our exosomes enhance regenerative signaling and skin health, providing a next-generation, cell-free therapeutic approach.

Natural Killer

Our NK cells deliver innate cytotoxicity against tumors, enabling rapid, precise, and scalable immunotherapy applications.

Message from Leadership

“Our vision is to make advanced cell therapies accessible to all — not just as treatments, but as pathways to lasting health and hope.”

Ethan Shen
Founder & Chairman of JY BioMed

Contact Us

bottom of page